Evidence map›Paper›PMID 37199796›Full record

ArticleEuropean radiology2023

Multiple sclerosis imaging in clinical practice: a European-wide survey of 428 centers and conclusions by the ESNR Working Group.

Jérôme Hodel, Meike W Vernooij, Mona K Beyer, Mariasavina Severino, Xavier Leclerc, Alain Créange, Abir Wahab, Neesmah Badat, Sarah Tolédano, Luc van den Hauwe and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 12 institutions in 7 countries.

Jérôme HodelDepartment of Radiology, Groupe Hospitalier Paris-Saint Joseph, Paris, France. jhodel@ghpsj.fr.ORCID http://orcid.org/0000-0002-9029-6890
Meike W VernooijDepartment of Radiology and Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Mona K BeyerDivision of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Mariasavina SeverinoNeuroradiology Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Xavier LeclercDepartment of Neuroradiology, Lille University Hospital, Lille, France.
Alain CréangeDepartment of Neurology, AP-HP, Henri Mondor University Hospital, Université Paris Est Créteil, 4391, Creteil, EA, France.
Abir WahabDepartment of Neurology, AP-HP, Henri Mondor University Hospital, Université Paris Est Créteil, 4391, Creteil, EA, France.
Neesmah BadatDepartment of Radiology, Groupe Hospitalier Paris-Saint Joseph, Paris, France.
Sarah TolédanoDepartment of Radiology, Groupe Hospitalier Paris-Saint Joseph, Paris, France.
Luc van den HauweDepartment of Radiology, Antwerp University Hospital, Antwerp, Belgium.
Ana RamosNeuroradiology, Department of Radiology, University Hospital, 12 de Octubre, Madrid, Spain.
Antonella CastellanoNeuroradiology Unit and CERMAC, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, 20132, Milan, Italy.
Alexandre KrainikDepartment of Neuroradiology, University Hospital of Grenoble, Grenoble, France.
Tarek YousryLysholm Department of Neuroradiology, UCLH National Hospital for Neurology and Neurosurgery, London, UK.
Àlex RoviraSection of Neuroradiology, Department of Radiology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Hôpital Paris Saint-Joseph · FRUniversité Paris-Est Créteil · FRAntwerp University Hospital · BECentre Hospitalier Universitaire de Grenoble · FRErasmus MC · NLIstituto Giannina Gaslini · ITNational Hospital for Neurology and Neurosurgery · GBOslo University Hospital · NOResearch Institute Hospital 12 de Octubre · ESUniversitat Autònoma de Barcelona · ESUniversité de Lille · FRVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate compliance with the available recommendations, we assessed the current clinical practice of imaging in the evaluation of multiple sclerosis (MS).

methodsAn online questionnaire was emailed to all members and affiliates. Information was gathered on applied MR imaging protocols, gadolinium-based contrast agents (GBCA) use and image analysis. We compared the survey results with the Magnetic Resonance Imaging in MS (MAGNIMS) recommendations considered as the reference standard.

resultsA total of 428 entries were received from 44 countries. Of these, 82% of responders were neuroradiologists. 55% performed more than ten scans per week for MS imaging. The systematic use of 3 T is rare (18%). Over 90% follow specific protocol recommendations with 3D FLAIR, T2-weighted and DWI being the most frequently used sequences. Over 50% use SWI at initial diagnosis and 3D gradient-echo T1-weighted imaging is the most used MRI sequence for pre- and post-contrast imaging. Mismatches with recommendations were identified including the use of only one sagittal T2-weighted sequence for spinal cord imaging, the systematic use of GBCA at follow-up (over 30% of institutions), a delay time shorter than 5 min after GBCA administration (25%) and an inadequate follow-up duration in pediatric acute disseminated encephalomyelitis (80%). There is scarce use of automated software to compare images or to assess atrophy (13% and 7%). The proportions do not differ significantly between academic and non-academic institutions.

conclusionsWhile current practice in MS imaging is rather homogeneous across Europe, our survey suggests that recommendations are only partially followed. CLINICAL RELEVANCE STATEMENT: Hurdles were identified, mainly in the areas of GBCA use, spinal cord imaging, underuse of specific MRI sequences and monitoring strategies. This work will help radiologists to identify the mismatches between their own practices and the recommendations and act upon them. KEY POINTS: • While current practice in MS imaging is rather homogeneous across Europe, our survey suggests that available recommendations are only partially followed. • Several hurdles have been identified through the survey that mainly lies in the areas of GBCA use, spinal cord imaging, underuse of specific MRI sequences and monitoring strategies.

Indexed as

Multiple SclerosisChildContrast MediaHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingSpinal CordSurveys and QuestionnairesContrast MediaContrast mediaGadoliniumMagnetic resonance imagingMultiple sclerosis

Identifiers

PMID37199796
OpenAlexW4377010545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.